Advances in biotechnology have improved the production and recombination of antibodies, leading to improvements in monoclonal antibody therapies.
Challenges and impact of rare diseases are faced by pharmacy stakeholders.
For decades, our growing and reliable arsenal of antibiotic and antimicrobial drugs created a dangerously cavalier attitude toward the nature of microbial pathogens and the true threat to public health they represent.
A qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.
As blockbuster drugs begin losing patent protection, pharmaceutical companies and pharmacists will address key marketplace changes.
We welcome our new editorial advisory board member, a leader and innovator in the industry.
Pharmacists can learn about educating patients on the risk of stroke in atrial fibrillation, monitoring anticoagulation therapy, and participating in disease management opportunities.
Ben Harding, a P4 student, discusses the scenario of being a pharmacy student during the COVID-19 pandemic.
Hypertension is a leading modifiable risk factor for heart disease and stroke.
Big changes are coming in the generic marketplace worldwide in the coming decade.
What could be causing this patient's involuntary, repetitive movements in her arms and legs?
The authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.
This analysis evaluates-from a US payer's perspective-the economic impact of using rivaroxaban versus enoxaparin for thromboprophylaxis following total hip or knee replacement surgery.
Current developments and innovations that will shape the future of specialty pharmacy.
Pharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.
Evidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
A chain pharmacy implements an integrated care program featuring pharmacists and health care coaches who provide in-store counseling.
A retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.
Consider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.
Dr. Goodin is the director of the division of pharmaceutical sciences at the Cancer Institute of New Jersey and associate professor of medicine, division of medical oncology, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, New Brunswick.
Empirical findings suggest that hyaluronan injections and diacerein are similarly effective. Yet the authors found that monetary savings could be realized when conservative treatment with diacerein is chosen.
Everything you need to know about WCH from diagnosis, treatment, and a review of the literature.
Given the disadvantages of opioids, including side effects and potential for addiction, non-opioid medications play an important role in pain management.
More than 86 million Americans over the age of 20 have prediabetes, 29 million Americans are diagnosed with diabetes, and another 8.1 million Americans are living with undiagnosed diabetes.
Sensors that can be attached to insulin pens, smart auto-injectors for patients with MS, sensors for inhalers, smart pill bottles, and bioingestible sensors are some of the evolving technologies.